Publishing Details Sample Clauses

Publishing Details. The ‘Publisher’ agrees that the ‘Author’ shall have the right to review and approve or disapprove the title of the ‘Article’ or sections of the ‘Article’ or any other parts of the ‘Article’, and the ‘Author’ shall be reasonably consulted on ‘Article’ design in Journal form. The ‘Publisher’ shall have the right to manufacture, distribute, advertise, promote, and publish the ‘Article’ in a style and manner which the ‘Publisher’ deems appropriate, including typesetting, paper, printing, binding, cover and/or jacket design, imprint, title, and price. Not with standing any editorial changes or revisions by the ‘Publisher’, the ‘Author’s’ warranties and indemnities under this Agreement shall remain in full force and effect.
AutoNDA by SimpleDocs
Publishing Details. The Publisher reserves the right: not to publish the Work; to revise or adapt the Work, with or without participation of the Author; to publish the Work and any revision or adaptation of the Work in different versions. The Publisher may use the Author's name and likeness in advertising and promoting the Work. Should this Agreement be terminated for any reason, the Publisher will have the right to delete the Author's name from the Work. The Publisher is not required to call upon the Author to undertake any revision, adaptation, or version of the Work. The Publisher may select any party it deems appropriate to undertake any revisions, adaptations, or versions of the Work.
Publishing Details. The Publisher agrees that the Author shall have the right to review and approve or disapprove the title of the Work, and the Author shall be reasonably consulted on cover design of the Work in book form. The Publisher shall have the right to manufacture, distribute, advertise, promote, and publish the Work in a style and manner which the Publisher deems appropriate, including typesetting, paper, printing, binding, cover and/or jacket design, imprint, title, and price. Notwithstanding any editorial changes or revisions by the Publisher, the Author’s warranties and indemnities under this Agreement shall remain in full force and effect.
Publishing Details. The Author and Publisher will jointly decide the title of the Work and the copy on the front cover (“Cover”) of the Work. The Publisher will consult with the Author and solicit the Author’s advice and ideas concerning the design of the Cover as well as soliciting input from the Publisher’s sales, marketing, design, and editorial representatives. The Publisher will take the lead in developing and refining the design of the Cover, and the Author and Publisher will jointly approve the final Cover design. The Publisher will also consult with the Author and seek the Author’s advice and ideas concerning the trim size and format of the Work, the type of cover, the design and layout of the interior text, and the plans for marketing the Work through direct mail, bookstore and trade distribution, special sales, media reviews and publicity, and other marketing channels; the Publisher will have the right to make final decisions in these matters. The Publisher will also have the right to decide all other publishing details, including prices at which the Work is sold, discounts and other sales policies, and paper, printing, and binding details. The Publisher will not be liable to the Author for damages, if any, resulting from the loss or destruction of manuscripts, art work, electronic files, printer’s files, or other materials connected to the publication of the Work.
Publishing Details. The Assignor and Assignee will jointly decide the title of the Work and the copy on the front cover (“Cover”) of the Work. The Assignee will consult with the Assignor and solicit the Assignor’s advice and ideas concerning the design of the Cover as well as soliciting input from the Assignee’s sales, marketing, design, and editorial representatives. The Assignee will take the lead in developing and refining the design of the Cover, and the Assignor and Assignee will jointly approve the final Cover design. The Assignee will also consult with the Assignor and seek the Assignor’s advice and ideas concerning the trim size and format of the Work, the type of cover, the design and layout of the interior text, and the plans for marketing the Work through direct mail, bookstore and trade distribution, special sales, media reviews and publicity, and other marketing channels; the Assignee will have the right to make final decisions in these matters. The Assignee will also have the right to decide all other publishing details, including prices at which the Work is sold, discounts and other sales policies, and paper, printing, and binding details. The Assignee will not be liable to the Assignor for damages, if any, resulting from the loss or destruction of manuscripts, art work, electronic files, printer’s files, or other materials connected to the publication of the Work.
Publishing Details. (a) The parties agree that the title of the Work shall be [TITLE]. Publisher shall have the right to produce, distribute, advertise, promote, license, and publish the Work in a style and manner which Publisher deems appropriate, including typesetting, paper, printing, binding, cover and/or jacket design, imprint, title, price, discounts, and promotions. Notwithstanding any editorial changes or revisions by Publisher, Author’s warranties and indemnities under this Agreement shall be binding and remain in full force and effect. (b) Publisher, in consultation with a graphic designer, will prepare the Work for formatting. Author understands that the format of the Work submitted to Publisher will not be used for the final Work. A change of formatting may include, but is not limited to, margins, overall size or length, fonts, pagination, and formats. (c) Publisher agrees that Author shall be reasonably consulted on the front and back cover and spine design of the Work in print form; and, a written approval of front and back cover and spine design by Author shall be submitted in writing to Publisher 30 days prior to scheduled Print Date. Print Date may be extended to allow for a 60-Day Remedy Period if Author and Publisher agree on front and back cover and spine redesign or alterations. Any costs associated with a redesign or alterations are paid by Publisher.

Related to Publishing Details

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Client Information Protected Health Information in any form including without limitation, Electronic Protected Health Information or Unsecured Protected Health Information (herein “PHI”);

  • MPS LOGO/PUBLICITY No Contractor shall use the MPS Logo in its literature or issue a press release about the subject of this Contract without prior written notice to and written approval of MPS’s Executive Director of Communications & Outreach.

  • Research Reports Distributor acknowledges that Dealer may prepare research reports relating to the Fund that are not to be used for marketing purposes (“Research Reports”). Distributor hereby authorizes Dealer to use the name of the Fund, Distributor and BREDS in Research Reports.

  • Patient Information Each Party agrees to abide by all laws, rules, regulations, and orders of all applicable supranational, national, federal, state, provincial, and local governmental entities concerning the confidentiality or protection of patient identifiable information and/or patients’ protected health information, as defined by any other applicable legislation in the course of their performance under this Agreement.

  • Root-­‐zone Information Publication ICANN’s publication of root-­‐zone contact information for the TLD will include Registry Operator and its administrative and technical contacts. Any request to modify the contact information for the Registry Operator must be made in the format specified from time to time by ICANN at xxxx://xxx.xxxx.xxx/domains/root/.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • zone Information Publication ICANN’s publication of root-zone contact information for the TLD will include Registry Operator and its administrative and technical contacts. Any request to modify the contact information for the Registry Operator must be made in the format specified from time to time by ICANN at xxxx://xxx.xxxx.xxx/domains/root/.

  • Alert Information As Alerts delivered via SMS, email and push notifications are not encrypted, we will never include your passcode or full account number. You acknowledge and agree that Alerts may not be encrypted and may include your name and some information about your accounts, and anyone with access to your Alerts will be able to view the contents of these messages.

  • Pricing Information Each Fund or its designee will furnish Plan Provider on each business day that the New York Stock Exchange is open for business ("Business Day"), with (i) net asset value information as of the close of trading (currently 4:00 p.m. Eastern Time) on the New York Stock Exchange or as at such later times at which a Fund's net asset value is calculated as specified in such Fund's prospectus ("Close of Trading"), (ii) dividend and capital gains information as it becomes available, and (iii) in the case of income Funds, the daily accrual or interest rate factor (mil rate). The Funds shall use their best efforts to provide such information to Plan Provider by 6:00 p.m. Central Time on the same Business Day. Distributor or its affiliate will provide Plan Provider (a) daily confirmations of Account activity within five Business Days after each day on which a purchase or redemption of Shares is effected for the particular Account, (b) if requested by Plan Provider, quarterly statements detailing activity in each Account within fifteen Business Days after the end of each quarter, and (c) such other reports as may be reasonably requested by Plan Provider.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!